Lazertinib Versus Gefitinib As First-Line Treatment for EGFR-mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset
CANCER RESEARCH AND TREATMENT（2024）
Key words
Non-small-cell lung carcinoma,Lazertinib,EGFR mutation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined